BlackThorn Therapeutics is a clinical-stage biopharmaceutical company. Founded by Alex Tkachenko in 2013, BlackThorn Therapeutics is backed by investors that include Alexandria Real Estate Equities, Alexandria Venture Investments, ARCH Venture Partners, GV, and Johnson & Johnson Innovation and is headquartered in South San Francisco.
FOUNDED:
2013
INDUSTRY:
Biopharma, Biotechnology, Health Care, Therapeutics
FOUNDERS:
Alex Tkachenko
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
